Suppr超能文献

中心静脉血栓形成患者的血液透析血管通路。

Vascular access for haemodialysis in patients with central vein thrombosis.

机构信息

Department of General, Vascular and Transplant Surgery Medical University of Warsaw, Poland.

出版信息

Eur J Vasc Endovasc Surg. 2011 Dec;42(6):842-9. doi: 10.1016/j.ejvs.2011.07.022. Epub 2011 Aug 17.

Abstract

OBJECTIVES

Dialysis-dependent patients often have central venous drainage complications. In patients with functioning arm arteriovenous fistula, this may result in venous hypertension, arm oedema and vascular access failure. Percutaneous angioplasty and stent implantation might be inadequate to resolve these issues. In these cases, new access can potentially be created with anastomosis to the subclavian vein, iliac vein or vena cava or by making a veno-venous graft to bypass the thrombosis. The aim of this study was to assess the utility of unusual bypasses in vascular access in patients with the central vein thrombosis.

MATERIALS

A total of 49 patients were treated. The mean number of previous vascular access surgery procedures was 7.6 (3-17). We performed 19 axillo-iliac, 14 axillo-axillary bypasses and 16 conduits from the arm fistula to the jugular (nine conduits) or subclavian (seven conduits) vein for haemodialysis purposes.

RESULTS

All fistulas except one were used for haemodialysis. One patient died before the first use of the fistula. At 12 months, the primary, primary assisted and secondary patency rates were 85.4%, 89.6% and 95.8%, respectively. The follow-up period ranged from 1 to 84 months.

CONCLUSION

Unusual grafts are an efficient option as a permanent vascular access for haemodialysis purposes in patients with central vein occlusion.

摘要

目的

依赖透析的患者常发生中心静脉引流并发症。在有功能的上肢动静脉瘘患者中,这可能导致静脉高压、手臂水肿和血管通路失败。经皮血管成形术和支架植入术可能不足以解决这些问题。在这些情况下,新的通路可以通过与锁骨下静脉、髂静脉或腔静脉吻合,或通过建立静脉-静脉移植物绕过血栓来潜在地创建。本研究旨在评估在中心静脉血栓形成患者中,不常见旁路在血管通路中的应用效果。

材料

共治疗 49 例患者。既往血管通路手术的平均次数为 7.6(3-17)次。我们进行了 19 例腋髂旁路、14 例腋腋旁路和 16 例从手臂瘘到颈内(9 例)或锁骨下(7 例)静脉的通路,用于血液透析。

结果

除 1 例外,所有瘘均用于血液透析。1 例患者在首次使用瘘管前死亡。12 个月时,一级、一级辅助和二级通畅率分别为 85.4%、89.6%和 95.8%。随访时间为 1 至 84 个月。

结论

在中心静脉闭塞的患者中,不常见的移植物是一种有效的永久性血液透析血管通路选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验